Ãngela Roco - Concepedia

Author

Ãngela Roco

University of Chile

Also Known As

ANGELA ROCO, Angela M. Roco, Angela Margarita Roco, Angela Roco, Ángela Roco, Ãngela Roco

Publications

448

Citations

H-Index

Concepts

All Affiliations

University of Chile Universidad de Extremadura Hospital San Juan de Dios Universidad Andrés Bello Hospital Clínico de la Universidad de Chile

ÃR

About

Ãngela Roco is an author at University of Chile specializing in medicine, genetic epidemiology, and epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	144
2	Public Health	2	2	112
3	Epidemiology	2	2	112
4	Genetic Medicine	2	2	112
5	Engineering	1	1	29

Ãngela Roco

Publications

329

Citations

H-Index

Page 1

	Year	Citations
In vitro biocontrol activity of Trichoderma harzianum on Alternaria alternata in the presence of growth regulators L. Pérez, Ãngela Roco Electronic Journal of Biotechnology	2001	88
Frequencies of 23 Functionally Significant Variant Alleles Related with Metabolism of Antineoplastic Drugs in the Chilean Population: Comparison with Caucasian and Asian Populations Ãngela Roco, Luis A. Quiñones, José A. G. Agúndez, Frontiers in Genetics GeneticsEpidemiology Of CancerGenetic EpidemiologyHuman PolymorphismPharmacotherapy	2012	78
Perception of the Usefulness of Drug/Gene Pairs and Barriers for Pharmacogenomics in Latin America Luis A. Quiñones, María A. Lavanderos, Juan Pablo Cayún, Current Drug Metabolism Genetic EpidemiologyPharmacotherapyLatin AmericaPharmacogenomics AreasGenetic Medicine	2014	34
Oligosaccharides released by pectinase treatment of Citrus limon seedlings are elicitors of the plant response Ãngela Roco, Patricia Castañeda, L. Pérez Phytochemistry EngineeringBotanyGlycobiologyPlant PathologyPlant Response	1993	29
MAPT1 gene rs1052553 variant is unrelated with the risk for restless legs syndrome Ãngela Roco, Félix Javier Jiménez‐Jiménez, Hortensia Alonso‐Navarro, Journal of Neural Transmission Genetic DisorderGeneticsRestless LegsMolecular GeneticsDisease Gene Identification	2012	20
Oral cancer susceptibility associated with the CYP1A1 and GSTM1 genotypes in Chilean individuals Karina Cordero‐Torres, Iris Espinoza, Dante Cáceres, Oncology Letters	2010	20
Association Study Among Candidate Genetic Polymorphisms and Chemotherapy-Related Severe Toxicity in Testicular Cancer Patients María A. Lavanderos, Juan Pablo Cayún, Ãngela Roco, Frontiers in Pharmacology	2019	19
A Pharmacogenetically Guided Acenocoumarol Dosing Algorithm for Chilean Patients: A Discovery Cohort Study Ãngela Roco, Elena Nieto, M Suárez, Frontiers in Pharmacology	2020	16
The role of phase I and II genetic polymorphisms, smoking, alcohol and cancer family history, in the risk of developing testicular cancer Ãngela Roco, Alejandra Lavanderos, Juan Pablo Cayún, Pharmacogenetics and Genomics	2019	13
Impact of CYP1A1, GSTM1, and GSTT1 polymorphisms in overall and specific prostate cancer survival Cristián Acevedo, Luis A. Quiñones, J. Catalan, Urologic Oncology Seminars and Original Investigations UrologyGenitourinary CancerMedicineGenetic EpidemiologyPathology	2014	12

Page 1